Scynexis (SCYX) Depreciation & Amortization (CF) (2013 - 2023)
Scynexis' (SCYX) quarterly Depreciation & Amortization (CF) came in at $129000.0 in Q4 2023, down 16.77% YoY from $155000.0 in Q4 2022, and down 12.24% on a QoQ basis from $147000.0 in Q3 2023.
Scynexis (SCYX) Depreciation & Amortization (CF) (2013 - 2023) Analysis & Trends
Scynexis (SCYX) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $129000.0 in Q4 2023.
- Quarterly Depreciation & Amortization (CF) fell 16.77% year-over-year to $129000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $129000.0 (down 78.71% YoY) and the FY2023 annual result came in at $580000.0, down 4.29% from the prior year.
- Depreciation & Amortization (CF) slipped to $129000.0 in Q4 2023, from $147000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $246000.0 in Q4 2021 to a low of $26000.0 in Q3 2019.
- A 5-year average of $93800.0 and a median of $88000.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2019 — Depreciation & Amortization (CF) soared 2900.0% — and 2022, when it sank 36.99%.
- Tracing SCYX's Depreciation & Amortization (CF) over 5 years: stood at $26000.0 in 2019, then soared by 353.85% to $118000.0 in 2020, then surged by 108.47% to $246000.0 in 2021, then sank by 36.99% to $155000.0 in 2022, then slipped by 16.77% to $129000.0 in 2023.
- The last three Depreciation & Amortization (CF) figures came in at $129000.0 (Q4 2023), $147000.0 (Q3 2023), and $153000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 129,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | 147,000.00 |
| Sep 30, 2023 | 147,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 151,000.00 |
| Mar 31, 2023 | 151,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Mar 31, 2022 | 155,000.00 |
| Dec 31, 2021 | 246,000.00 |
| Dec 31, 2021 | 246,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Sep 30, 2021 | 48,000.00 |